Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3605-3612, Vol. 74, No. 8
Unit of Avian Health, Department of
Microbiology and Immunology, College of Veterinary Medicine,
Cornell University, Ithaca, New York 14853
Received 28 October 1999/Accepted 25 January 2000
The replication of Marek's disease herpesvirus (MDV) and
herpesvirus of turkeys (HVT) in chicken embryo fibroblast (CEF)
cultures was inhibited by the addition of
S-nitroso-N-acetylpenicillamine, a nitric oxide
(NO)-generating compound, in a dose-dependent manner. Treatment of CEF
culture, prepared from 11-day-old embryos, with recombinant chicken
gamma interferon (rChIFN-
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Inhibitory Effects of Nitric Oxide and Gamma Interferon on In
Vitro and In Vivo Replication of Marek's Disease Virus
and
) and lipopolysaccharide (LPS) resulted in
production of NO which was suppressed by the addition of
NG-monomethyl L-arginine (NMMA), an
inhibitor of inducible NO synthase (iNOS). Incubation of CEF cultures
for 72 h prior to treatment with rChIFN-
plus LPS was required
for optimal NO production. Significant differences in NO production
were observed in CEF derived from MDV-resistant N2a (major
histocompatibility complex [MHC],
B21B21) and
MDV-susceptible S13 (MHC,
B13B13) and P2a (MHC,
B19B19) chickens.
N2a-derived CEF produced NO earlier and at higher levels than CEF from
the other two lines. The lowest production of NO was detected in
P2a-derived CEF. NO production in chicken splenocyte cultures followed
a similar pattern, with the highest levels of NO produced in cultures
from N2a chickens and the lowest levels produced in cultures from P2a
chickens. Replication of MDV and HVT was significantly inhibited in CEF
cultures treated with rChIFN-
plus LPS and producing NO. The
addition of NMMA to CEF treated with rChIFN-
plus LPS reduced the
inhibition. MDV infection of chickens treated with
S-methylisothiourea, an inhibitor of iNOS, resulted in
increased virus load compared to nontreated chickens. These results
suggest that NO may play an important role in control of MDV
replication in vivo.
*
Corresponding author. Mailing address: Unit of Avian
Health, Department of Microbiology and Immunology, College of
Veterinary Medicine, Cornell University, Ithaca, NY 14853. Phone: (607)
253-4032. Fax: (607) 253-3384. E-mail: kas24{at}cornell.edu.
Present address: Department of Molecular and Cellular Engineering,
The Institute for Human Gene Therapy, University of Pennsylvania School
of Medicine, Philadelphia, PA 19104.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|